Results 251 to 260 of about 87,801 (334)

Hypertrophic cardiomyopathy combined with renal and adrenal aplasia in a male with Noonan syndrome from RAF1 variant

open access: yes
ESC Heart Failure, Volume 12, Issue 3, Page 2371-2376, June 2025.
Ying Wang   +7 more
wiley   +1 more source

Impact of Left Ventricular‐Vascular Interaction on Long‐Term Outcome After Heart Transplantation

open access: yesClinical Transplantation, Volume 39, Issue 5, May 2025.
ABSTRACT Background and aim To compare pressure‐volume (PV) derivative variables between HT patients and healthy controls and to assess their impact on long‐term outcome. Methods In this single‐center retrospective study, HT patients surviving their first post‐HT year with left ventricular ejection fraction (LVEF) ≥50%, absence of allograft ...
Mattia Corianò   +10 more
wiley   +1 more source

Left Atrial Thrombus in the Setting of Mitral Stenosis. [PDF]

open access: yesMethodist Debakey Cardiovasc J, 2023
Abdelkarim O, Saleh Y, Nabi F.
europepmc   +1 more source

Echocardiographic Assessment of Cardiac Phenotype Predicts Complications and Guides Intensive Care Management Following Pulmonary Valve Balloon Dilation in Neonates With Pulmonary Atresia/Critical Pulmonary Stenosis With Intact Ventricular Septum

open access: yesEchocardiography, Volume 42, Issue 5, May 2025.
Pulmonary atresia/critical pulmonary stenosis with intact ventricular septum presents with varying degrees of right ventricular hypoplasia. Echocardiographic assessment of ventricular phenotype predicts post‐valvuloplasty complications and guides intensive care management, providing essential support for cardiologists and cardiac intensivists ...
Patrizio Moras   +7 more
wiley   +1 more source

Apixaban in patients with nonvalvular atrial fibrillation, heart failure and low body weight: A report from a global federated research dataset

open access: yesEuropean Journal of Clinical Investigation, Volume 55, Issue 5, May 2025.
In a cohort of 155,152 patients with atrial fibrillation, heart failure and low body weight, patients weighting <60 kg faced a higher risk of adverse events compared to those in the reference BW (60–100 kg), regardless of treatment. Apixaban demonstrated a lower risk of ischaemic stroke/systemic embolism, bleedings (including intracranial hemorrhage ...
Luca Monzo   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy